Targeted therapy with humanized anti-CD33 monoclonal antibody (HuM195) reduces residual disease in acute promyelocytic leukemia Meeting Abstract

  

Authors:	Jurcic, J. G.; Caron, P. C.; DeBlasio, A.; Dumont, L.; Warrell, R. P. Jr; Scheinberg, D. A.
Abstract Title:	Targeted therapy with humanized anti-CD33 monoclonal antibody (HuM195) reduces residual disease in acute promyelocytic leukemia
Meeting Title:	37th Annual Meeting of the American Society of Hematology
Journal Title:	Blood
Volume:	86
Issue:	10 Suppl. 1
Meeting Dates:	1995 Dec 1-5
Meeting Location:	Seattle, WA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	1995-11-15
Start Page:	517a
Language:	English
ACCESSION:	WOS:A1995TH91002057
PROVIDER:	wos
PUBMED:	7579376
Notes:	Meeting Abstract: 2057 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/136094